CAROTID STENOSIS Clinical Trial
— STATEMENTOfficial title:
Plaque and Brain Inflammation in Symptomatic Carotid Stenosis: Role of the Ficolin-2
Carotid artery stenosis is observed in about 3% of ≥ 60 years subjects and accounts for around 10-20% of all ischemic strokes. Beyond the degree of stenosis, plaque composition affects the risk of ischemic stroke. Identification of patients with vulnerable plaques at higher risk of stroke who might benefit from carotid revascularization is crucial. A growing body of evidence suggests that the lectin pathway of the complement system, and especially the ficolin-2, is involved in atherosclerosis. It has been hypothesized that circulating levels of ficolin-2 increase during chronic inflammatory conditions (i.e. growing atherosclerotic plaque) whereas they fall during sub-acute or acute inflammatory conditions (i.e. plaque rupture and acute ischemic stroke) because of consumption (binding to targets). Therefore, ficolin-2 has been proposed as a biomarker informing on the specific state of the plaque. However, in acute ischemic stroke due to carotid stenosis, both plaque rupture and stroke injury contribute to lectin pathway activation, thus affecting circulating levels of ficolin-2. Until now, the relative contribution of plaque and brain inflammation on circulating levels of ficolin-2 has not been documented. In the present study the investigators aim to assess the association between circulating levels of ficolin-2 and carotid and brain inflammation on [18F]DPA-714 positron emission tomography (PET)/MRI in patients with transient ischemic attack or acute ischemic stroke due to carotid stenosis. For that purpose, the investigators intend to include 30 patients with transient ischemic attack or acute ischemic stroke due to ≥ 50%. carotid stenosis. Each patient will have a measure of plasmatic level of ficolin-2 as well a [18F]DPA-714 PET/MRI to quantify the fixation of the radiotracer on carotid and brain.
Status | Not yet recruiting |
Enrollment | 20 |
Est. completion date | January 30, 2025 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients 18 years or over, - Signed written informed consent before any study specific intervention, - Probable ipsilateral transient ischemic attack (TIA - which involve a focal speech/language, motor or visual deficit referable to the distribution of a carotid artery and lasting less than 24 hours from the onset) OR ischemic stroke = 24h from the onset, - Atherosclerotic carotid stenosis between 50% and 99% (NASCET method), as confirmed by one of the imaging examinations (among: Doppler ultrasound, MR angiography, CT angiography, catheter angiography) performed after index TIA or ischemic stroke Exclusion Criteria: - Patients with inflammatory or autoimmune disease, hepatocellular insufficiency, acute or chronic infection, active malignancy, myocardial infarction or major surgery within the previous 30 days of index hospitalization according to the investigator, - Patients with severe renal insufficiency (estimated GFR < 30 ml/min at inclusion or known dialysis), - Patients with contraindication to MRI (agitation, claustrophobia, pacemaker, metallic (ferromagnetic) body, a known allergy to gadolinium) according to the investigator's judgment, - Patients with modified Rankin score greater than 3, - Patients currently enrolled in another clinical trial including investigational medicinal products, - Female patient who is pregnant or lactating, or is of child-bearing and who did not agree to use highly effective methods of birth control throughout the study, - Patient without health coverage, - Patient under legal protection |
Country | Name | City | State |
---|---|---|---|
France | Service de Neurologie vasculaire / CarMeN U1060 INSERM Hôpital Neurologique Pierre Wertheimer - GHE | Bron |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Correlation between: - Plasma levels of ficolin-2 at day 5 in ng/ml, - Metabolic data on [18F]DPA-714 PET/MRI | To assess the association between circulating levels of ficolin-2 and carotid and brain inflammation on [18F]DPA-714 PET/MRI in patients with transient ischemic attack or acute ischemic stroke due to carotid stenosis | day 5 | |
Secondary | Correlation between plasma levels of ficolin-2 at day 5 in ng/mL with morphological data of the brain and carotid plaque assessed by MRI | To assess if plasma levels of ficolin-2 in patients with TIA or acute ischemic stroke due to carotid stenosis correlate with:
1. morphological data: of the plaque: presence of intraplaque hemorrhage, lipid-rich necrotic core, thinning/rupture of the fibrous cap on carotid plaque MRI of the brain: infarct size, presence of hemorrhagic transformation, blood-brain barrier leakage |
day 5 | |
Secondary | Correlation between plasma levels of ficolin-2 at day 5 in ng/mL with morphological data of the brain and carotid plaque assessed by MRI | To assess if plasma levels of ficolin-2 in patients with TIA or acute ischemic stroke due to carotid stenosis correlate with:
- histological data of the retrieved plaque: hemorrhagic content, lipid core, cholesterol cleft areas, ratio between thickness of tunica media and total thickness of tunica, rupture, intraplaque deposition of ficolin-2, macrophages and neutrophils infiltration |
day 15 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03631381 -
Retrospective Study of Carotid Surgery in Dijon
|
||
Completed |
NCT05437991 -
Ultrasonographic Morphology Assessment of Low-grade Carotid Stenosis
|
N/A | |
Completed |
NCT02722720 -
Carotid Arteries Stenting Complications: Transradial Approach Versus Transfemoral
|
N/A | |
Completed |
NCT02336958 -
Ultrasound Guided Intermediate Cervical Plexus Block and Additional Perivascular Local Anesthetic Infiltration
|
N/A | |
Completed |
NCT02630862 -
Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization
|
N/A | |
Completed |
NCT00536796 -
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
|
N/A | |
Recruiting |
NCT05566301 -
Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)
|
||
Completed |
NCT03303534 -
Short-Term Endogenous Hydrogen Sulfide Upregulation
|
N/A | |
Completed |
NCT01480206 -
Overlay of 3D Scans on Live Fluoroscopy for Endovascular Procedures in the Hybrid OR
|
||
Recruiting |
NCT05250349 -
TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure
|
||
Recruiting |
NCT05845710 -
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
|
N/A | |
Recruiting |
NCT01732523 -
Predictive Value of Neovascularization Within Asymptomatic Carotis Stenosis on CEUS
|
||
Completed |
NCT01315288 -
A Randomized Trial of Clinical Decision Making in Asymptomatic Carotid Stenosis
|
N/A | |
Withdrawn |
NCT00401921 -
A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
|
Phase 2 | |
Recruiting |
NCT01273350 -
A Prospective, Non-Randomized, Evaluation of Low-Risk Patients Undergoing Carotid Stenting With ANgiomax (Bivalirudin)
|
N/A | |
Completed |
NCT03215550 -
PET-MRI Imaging in Patients With Symptomatic Carotid Artery Stenosis
|
||
Completed |
NCT03215563 -
PET-MRI Imaging in Patients With Acute Neurovascular Syndrome
|
||
Completed |
NCT04553549 -
Safety and Feasibility of the Infinity Catheter for Radial Access
|
||
Completed |
NCT03596229 -
Major Adverse Cardiac Events After Carotid Endarterectomy
|
||
Completed |
NCT04255316 -
Modified Method of Eversion Carotid Endarterectomy in Patients With Extensive Atherosclerotic Disease of Carotid Bifurcation
|
N/A |